LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway

Radiation resistance poses a major clinical challenge in breast cancer (BC) treatment, but little is known about how long noncoding RNA (lncRNA) may regulate this phenomenon. Here, we reported that DUXAP8 was highly expressed in radioresistant BC tissues, and high expression of DUXAP8 was associated...

Full description

Bibliographic Details
Main Authors: Changjiang Lei, Shaoting Li, Ying Fan, Li Hua, Qingyun Pan, Yuan Li, Zhixiong Long, Rui Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Cancer Biology & Therapy
Subjects:
Online Access:http://dx.doi.org/10.1080/15384047.2022.2132008
_version_ 1797404061127933952
author Changjiang Lei
Shaoting Li
Ying Fan
Li Hua
Qingyun Pan
Yuan Li
Zhixiong Long
Rui Yang
author_facet Changjiang Lei
Shaoting Li
Ying Fan
Li Hua
Qingyun Pan
Yuan Li
Zhixiong Long
Rui Yang
author_sort Changjiang Lei
collection DOAJ
description Radiation resistance poses a major clinical challenge in breast cancer (BC) treatment, but little is known about how long noncoding RNA (lncRNA) may regulate this phenomenon. Here, we reported that DUXAP8 was highly expressed in radioresistant BC tissues, and high expression of DUXAP8 was associated with poor prognosis. We found that the overexpression of DUXAP8 promoted radioresistance, while the knockdown of DUXAP8 expression increased radiosensitivity. Further studies revealed that DUXAP8 enhanced the radioresistance of BC cells by activating the PI3K/AKT/mTOR pathway and by repressing the expression of E-cadherin and RHOB through interaction with EZH2. Together, our work demonstrates that the overexpression of DUXAP8 promotes the resistance of BC cells toward radiation through modulating PI3K/AKT/mTOR pathway and EZH2-E-cadherin/RHOB axis. Targeting DUXAP8 may serve as a potential strategy to overcome radioresistance in BC treatment.
first_indexed 2024-03-09T02:47:40Z
format Article
id doaj.art-a7d43be86b45424b86ac1335870a9f26
institution Directory Open Access Journal
issn 1538-4047
1555-8576
language English
last_indexed 2024-03-09T02:47:40Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Cancer Biology & Therapy
spelling doaj.art-a7d43be86b45424b86ac1335870a9f262023-12-05T15:58:14ZengTaylor & Francis GroupCancer Biology & Therapy1538-40471555-85762022-12-0123111310.1080/15384047.2022.21320082132008LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathwayChangjiang Lei0Shaoting Li1Ying Fan2Li Hua3Qingyun Pan4Yuan Li5Zhixiong Long6Rui Yang7the Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of Wuhanthe Fifth Hospital of WuhanRadiation resistance poses a major clinical challenge in breast cancer (BC) treatment, but little is known about how long noncoding RNA (lncRNA) may regulate this phenomenon. Here, we reported that DUXAP8 was highly expressed in radioresistant BC tissues, and high expression of DUXAP8 was associated with poor prognosis. We found that the overexpression of DUXAP8 promoted radioresistance, while the knockdown of DUXAP8 expression increased radiosensitivity. Further studies revealed that DUXAP8 enhanced the radioresistance of BC cells by activating the PI3K/AKT/mTOR pathway and by repressing the expression of E-cadherin and RHOB through interaction with EZH2. Together, our work demonstrates that the overexpression of DUXAP8 promotes the resistance of BC cells toward radiation through modulating PI3K/AKT/mTOR pathway and EZH2-E-cadherin/RHOB axis. Targeting DUXAP8 may serve as a potential strategy to overcome radioresistance in BC treatment.http://dx.doi.org/10.1080/15384047.2022.2132008lncrna duxap8aktezh2breast cancerradioresistance
spellingShingle Changjiang Lei
Shaoting Li
Ying Fan
Li Hua
Qingyun Pan
Yuan Li
Zhixiong Long
Rui Yang
LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
Cancer Biology & Therapy
lncrna duxap8
akt
ezh2
breast cancer
radioresistance
title LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
title_full LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
title_fullStr LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
title_full_unstemmed LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
title_short LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway
title_sort lncrna duxap8 induces breast cancer radioresistance by modulating the pi3k akt mtor pathway and the ezh2 e cadherin rhob pathway
topic lncrna duxap8
akt
ezh2
breast cancer
radioresistance
url http://dx.doi.org/10.1080/15384047.2022.2132008
work_keys_str_mv AT changjianglei lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT shaotingli lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT yingfan lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT lihua lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT qingyunpan lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT yuanli lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT zhixionglong lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway
AT ruiyang lncrnaduxap8inducesbreastcancerradioresistancebymodulatingthepi3kaktmtorpathwayandtheezh2ecadherinrhobpathway